The Cancer Therapeutics CRC structural biology team draws on 50-plus years of protein crystallography knowledge and has successfully determined the structures of several of the CRC’s target proteins and protein/inhibitor complexes. As well as high quality in-house crystallization labs, the CRC has access to multiple X-ray facilities (Rigaku MicroMax 007HF with RAXIS4++ area detector and cryocooling) and to the Australian Synchrotron.